Cargando…

The role of Interactive Binocular Treatment system in amblyopia therapy

PURPOSE: To determine the role of Interactive Binocular Treatment (I-BiT™) as a complementary method of patching in amblyopia therapy. METHODS: In this randomized clinical trial study, 50 unilateral amblyopic children (25 male/25 female) between 3 and 10 years with either best corrected visual acuit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajavi, Zhale, Sabbaghi, Hamideh, Amini Sharifi, Ebrahim, Behradfar, Narges, Yaseri, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093783/
https://www.ncbi.nlm.nih.gov/pubmed/27830207
http://dx.doi.org/10.1016/j.joco.2016.07.005
_version_ 1782465000959377408
author Rajavi, Zhale
Sabbaghi, Hamideh
Amini Sharifi, Ebrahim
Behradfar, Narges
Yaseri, Mehdi
author_facet Rajavi, Zhale
Sabbaghi, Hamideh
Amini Sharifi, Ebrahim
Behradfar, Narges
Yaseri, Mehdi
author_sort Rajavi, Zhale
collection PubMed
description PURPOSE: To determine the role of Interactive Binocular Treatment (I-BiT™) as a complementary method of patching in amblyopia therapy. METHODS: In this randomized clinical trial study, 50 unilateral amblyopic children (25 male/25 female) between 3 and 10 years with either best corrected visual acuity (BCVA) ≤20/30 in the amblyopic eye or a difference of BCVA ≥ 2 lines between the two eyes were included. They were randomly classified into the case and control groups (25 in each). Patching was recommended in both groups, and cases also received I-BiT™. Cases were asked to play I-BiT™ games through appropriate glasses with conjugate colored filters. Moving and fixed targets were shown to the amblyopic and non-amblyopic eyes, respectively. Playing games was continued 20 min in each session for 5 days a week within one month (total time: 6.6 h). Patching was continued for one month more in both groups to evaluate the continuous effect of I-BiT™. BCVA was measured at baseline, one month after beginning I-BiT™, and one month after cessation of I-BiT™. RESULTS: BCVA of amblyopic eyes in cases and controls were 0.34 ± 0.14 and 0.33 ± 0.17LogMAR at baseline which improved to 0.17 ± 0.14 and 0.26 ± 0.17 at one month, respectively. The difference was significant in each group (p < 0.001 for cases and p = 0.024 for controls) with more improvement in the case group (p < 0.001). One month after cessation of I-BiT™, BCVA difference between the two groups was not statistically significant. There was no case with recurrence of amblyopia. CONCLUSION: Based on our results, I-BiT™ seems to be effective in amblyopia therapy accompanied with patching. We recommend comparing I-BiT™ alone with patching in further studies. ClinicalTrials.gov Identifier: NCT02740725.
format Online
Article
Text
id pubmed-5093783
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-50937832016-11-09 The role of Interactive Binocular Treatment system in amblyopia therapy Rajavi, Zhale Sabbaghi, Hamideh Amini Sharifi, Ebrahim Behradfar, Narges Yaseri, Mehdi J Curr Ophthalmol Original Research PURPOSE: To determine the role of Interactive Binocular Treatment (I-BiT™) as a complementary method of patching in amblyopia therapy. METHODS: In this randomized clinical trial study, 50 unilateral amblyopic children (25 male/25 female) between 3 and 10 years with either best corrected visual acuity (BCVA) ≤20/30 in the amblyopic eye or a difference of BCVA ≥ 2 lines between the two eyes were included. They were randomly classified into the case and control groups (25 in each). Patching was recommended in both groups, and cases also received I-BiT™. Cases were asked to play I-BiT™ games through appropriate glasses with conjugate colored filters. Moving and fixed targets were shown to the amblyopic and non-amblyopic eyes, respectively. Playing games was continued 20 min in each session for 5 days a week within one month (total time: 6.6 h). Patching was continued for one month more in both groups to evaluate the continuous effect of I-BiT™. BCVA was measured at baseline, one month after beginning I-BiT™, and one month after cessation of I-BiT™. RESULTS: BCVA of amblyopic eyes in cases and controls were 0.34 ± 0.14 and 0.33 ± 0.17LogMAR at baseline which improved to 0.17 ± 0.14 and 0.26 ± 0.17 at one month, respectively. The difference was significant in each group (p < 0.001 for cases and p = 0.024 for controls) with more improvement in the case group (p < 0.001). One month after cessation of I-BiT™, BCVA difference between the two groups was not statistically significant. There was no case with recurrence of amblyopia. CONCLUSION: Based on our results, I-BiT™ seems to be effective in amblyopia therapy accompanied with patching. We recommend comparing I-BiT™ alone with patching in further studies. ClinicalTrials.gov Identifier: NCT02740725. Elsevier 2016-08-09 /pmc/articles/PMC5093783/ /pubmed/27830207 http://dx.doi.org/10.1016/j.joco.2016.07.005 Text en © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Rajavi, Zhale
Sabbaghi, Hamideh
Amini Sharifi, Ebrahim
Behradfar, Narges
Yaseri, Mehdi
The role of Interactive Binocular Treatment system in amblyopia therapy
title The role of Interactive Binocular Treatment system in amblyopia therapy
title_full The role of Interactive Binocular Treatment system in amblyopia therapy
title_fullStr The role of Interactive Binocular Treatment system in amblyopia therapy
title_full_unstemmed The role of Interactive Binocular Treatment system in amblyopia therapy
title_short The role of Interactive Binocular Treatment system in amblyopia therapy
title_sort role of interactive binocular treatment system in amblyopia therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093783/
https://www.ncbi.nlm.nih.gov/pubmed/27830207
http://dx.doi.org/10.1016/j.joco.2016.07.005
work_keys_str_mv AT rajavizhale theroleofinteractivebinoculartreatmentsysteminamblyopiatherapy
AT sabbaghihamideh theroleofinteractivebinoculartreatmentsysteminamblyopiatherapy
AT aminisharifiebrahim theroleofinteractivebinoculartreatmentsysteminamblyopiatherapy
AT behradfarnarges theroleofinteractivebinoculartreatmentsysteminamblyopiatherapy
AT yaserimehdi theroleofinteractivebinoculartreatmentsysteminamblyopiatherapy
AT rajavizhale roleofinteractivebinoculartreatmentsysteminamblyopiatherapy
AT sabbaghihamideh roleofinteractivebinoculartreatmentsysteminamblyopiatherapy
AT aminisharifiebrahim roleofinteractivebinoculartreatmentsysteminamblyopiatherapy
AT behradfarnarges roleofinteractivebinoculartreatmentsysteminamblyopiatherapy
AT yaserimehdi roleofinteractivebinoculartreatmentsysteminamblyopiatherapy